The global market for Adult Attention Deficit and Hyperactivity Disorder was valued at US$ 12600 million in the year 2024 and is projected to reach a revised size of US$ 20090 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Adult Attention Deficit and Hyperactivity Disorder Market

Attention deficit hyperactivity disorder (ADHD) is a condition that affects people"s behaviour. People with ADHD can seem restless, may have trouble concentrating and may act on impulse.

The Attention Deficit and Hyperactivity Disorder (ADHD) market is driven by the rising awareness of the disorder and its diagnosis, coupled with the increasing prevalence of ADHD among children and adults. ADHD is a neurodevelopmental disorder characterized by symptoms of inattention, hyperactivity, and impulsivity. The growing recognition of the impact of ADHD on daily life, educational performance, and workplace productivity contributes to market growth as individuals and healthcare providers seek effective treatment options. Moreover, advancements in diagnostic methods, therapy approaches, and medication options align with improved management of ADHD symptoms. However, the market also faces challenges, including accurate diagnosis and tailoring treatment plans to individual patient needs. Additionally, addressing concerns about overdiagnosis and appropriate medication usage can pose obstacles for healthcare professionals. To succeed, stakeholders must focus on providing comprehensive assessment and tailored interventions, fostering public awareness, and addressing the challenges to meet the increasing demand for accurate diagnosis and effective management of ADHD.

This report aims to provide a comprehensive presentation of the global market for Adult Attention Deficit and Hyperactivity Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adult Attention Deficit and Hyperactivity Disorder.

The Adult Attention Deficit and Hyperactivity Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Adult Attention Deficit and Hyperactivity Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Adult Attention Deficit and Hyperactivity Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Adult Attention Deficit and Hyperactivity Disorder Market Report

Report Metric	Details
Report Name	Adult Attention Deficit and Hyperactivity Disorder Market
Accounted market size in year	US$ 12600 million
Forecasted market size in 2031	US$ 20090 million
CAGR	7.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Stimulant Non-stimulant
Segment by Application	Hospital Retail Pharmacy Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Adult Attention Deficit and Hyperactivity Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Adult Attention Deficit and Hyperactivity Disorder Market growing?

Ans: The Adult Attention Deficit and Hyperactivity Disorder Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Adult Attention Deficit and Hyperactivity Disorder Market size in 2031?

Ans: The Adult Attention Deficit and Hyperactivity Disorder Market size in 2031 will be US$ 20090 million.

Who are the main players in the Adult Attention Deficit and Hyperactivity Disorder Market report?

Ans: The main players in the Adult Attention Deficit and Hyperactivity Disorder Market are Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma

What are the Application segmentation covered in the Adult Attention Deficit and Hyperactivity Disorder Market report?

Ans: The Applications covered in the Adult Attention Deficit and Hyperactivity Disorder Market report are Hospital, Retail Pharmacy, Others

What are the Type segmentation covered in the Adult Attention Deficit and Hyperactivity Disorder Market report?

Ans: The Types covered in the Adult Attention Deficit and Hyperactivity Disorder Market report are Stimulant, Non-stimulant

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Stimulant

1.2.3 Non-stimulant

1.3 Market by Application

1.3.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Perspective (2020-2031)

2.2 Global Adult Attention Deficit and Hyperactivity Disorder Growth Trends by Region

2.2.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Region (2020-2025)

2.2.3 Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031)

2.3 Adult Attention Deficit and Hyperactivity Disorder Market Dynamics

2.3.1 Adult Attention Deficit and Hyperactivity Disorder Industry Trends

2.3.2 Adult Attention Deficit and Hyperactivity Disorder Market Drivers

2.3.3 Adult Attention Deficit and Hyperactivity Disorder Market Challenges

2.3.4 Adult Attention Deficit and Hyperactivity Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Adult Attention Deficit and Hyperactivity Disorder Players by Revenue

3.1.1 Global Top Adult Attention Deficit and Hyperactivity Disorder Players by Revenue (2020-2025)

3.1.2 Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Adult Attention Deficit and Hyperactivity Disorder Revenue

3.4 Global Adult Attention Deficit and Hyperactivity Disorder Market Concentration Ratio

3.4.1 Global Adult Attention Deficit and Hyperactivity Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Adult Attention Deficit and Hyperactivity Disorder Revenue in 2024

3.5 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder Head office and Area Served

3.6 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Product and Application

3.7 Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Adult Attention Deficit and Hyperactivity Disorder Breakdown Data by Type

4.1 Global Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Type (2020-2025)

4.2 Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031)

5 Adult Attention Deficit and Hyperactivity Disorder Breakdown Data by Application

5.1 Global Adult Attention Deficit and Hyperactivity Disorder Historic Market Size by Application (2020-2025)

5.2 Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Adult Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

6.2 North America Adult Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

6.4 North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

7.2 Europe Adult Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

7.4 Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

8.2 Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

9.2 Latin America Adult Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

9.4 Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size (2020-2031)

10.2 Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Adult Attention Deficit and Hyperactivity Disorder Introduction

11.1.4 Takeda Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.1.5 Takeda Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Details

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Introduction

11.2.4 Johnson & Johnson Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.2.5 Johnson & Johnson Recent Development

11.3 Novartis

11.3.1 Novartis Company Details

11.3.2 Novartis Business Overview

11.3.3 Novartis Adult Attention Deficit and Hyperactivity Disorder Introduction

11.3.4 Novartis Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.3.5 Novartis Recent Development

11.4 Eli Lilly

11.4.1 Eli Lilly Company Details

11.4.2 Eli Lilly Business Overview

11.4.3 Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Introduction

11.4.4 Eli Lilly Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.4.5 Eli Lilly Recent Development

11.5 Tris Pharma

11.5.1 Tris Pharma Company Details

11.5.2 Tris Pharma Business Overview

11.5.3 Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Introduction

11.5.4 Tris Pharma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.5.5 Tris Pharma Recent Development

11.6 Neos Therapeutics

11.6.1 Neos Therapeutics Company Details

11.6.2 Neos Therapeutics Business Overview

11.6.3 Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Introduction

11.6.4 Neos Therapeutics Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.6.5 Neos Therapeutics Recent Development

11.7 Mallinckrodt

11.7.1 Mallinckrodt Company Details

11.7.2 Mallinckrodt Business Overview

11.7.3 Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Introduction

11.7.4 Mallinckrodt Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.7.5 Mallinckrodt Recent Development

11.8 Amneal Pharmaceuticals

11.8.1 Amneal Pharmaceuticals Company Details

11.8.2 Amneal Pharmaceuticals Business Overview

11.8.3 Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Introduction

11.8.4 Amneal Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.8.5 Amneal Pharmaceuticals Recent Development

11.9 Noven Pharmaceuticals

11.9.1 Noven Pharmaceuticals Company Details

11.9.2 Noven Pharmaceuticals Business Overview

11.9.3 Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Introduction

11.9.4 Noven Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.9.5 Noven Pharmaceuticals Recent Development

11.10 Purdue Parma

11.10.1 Purdue Parma Company Details

11.10.2 Purdue Parma Business Overview

11.10.3 Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Introduction

11.10.4 Purdue Parma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

11.10.5 Purdue Parma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Amneal Pharmaceuticals

Noven Pharmaceuticals

Purdue Parma

List of Tables

Table 1. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Stimulant

Table 3. Key Players of Non-stimulant

Table 4. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2025)

Table 8. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2026-2031)

Table 10. Adult Attention Deficit and Hyperactivity Disorder Market Trends

Table 11. Adult Attention Deficit and Hyperactivity Disorder Market Drivers

Table 12. Adult Attention Deficit and Hyperactivity Disorder Market Challenges

Table 13. Adult Attention Deficit and Hyperactivity Disorder Market Restraints

Table 14. Global Adult Attention Deficit and Hyperactivity Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Players (2020-2025)

Table 16. Global Top Adult Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Attention Deficit and Hyperactivity Disorder as of 2024)

Table 17. Ranking of Global Top Adult Attention Deficit and Hyperactivity Disorder Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Adult Attention Deficit and Hyperactivity Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Headquarters and Area Served

Table 20. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Product and Application

Table 21. Global Key Players of Adult Attention Deficit and Hyperactivity Disorder, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2020-2025)

Table 25. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Type (2026-2031)

Table 27. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2020-2025)

Table 29. Global Adult Attention Deficit and Hyperactivity Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Adult Attention Deficit and Hyperactivity Disorder Revenue Market Share by Application (2026-2031)

Table 31. North America Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 46. Takeda Company Details

Table 47. Takeda Business Overview

Table 48. Takeda Adult Attention Deficit and Hyperactivity Disorder Product

Table 49. Takeda Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 50. Takeda Recent Development

Table 51. Johnson & Johnson Company Details

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson Adult Attention Deficit and Hyperactivity Disorder Product

Table 54. Johnson & Johnson Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Novartis Company Details

Table 57. Novartis Business Overview

Table 58. Novartis Adult Attention Deficit and Hyperactivity Disorder Product

Table 59. Novartis Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 60. Novartis Recent Development

Table 61. Eli Lilly Company Details

Table 62. Eli Lilly Business Overview

Table 63. Eli Lilly Adult Attention Deficit and Hyperactivity Disorder Product

Table 64. Eli Lilly Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 65. Eli Lilly Recent Development

Table 66. Tris Pharma Company Details

Table 67. Tris Pharma Business Overview

Table 68. Tris Pharma Adult Attention Deficit and Hyperactivity Disorder Product

Table 69. Tris Pharma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 70. Tris Pharma Recent Development

Table 71. Neos Therapeutics Company Details

Table 72. Neos Therapeutics Business Overview

Table 73. Neos Therapeutics Adult Attention Deficit and Hyperactivity Disorder Product

Table 74. Neos Therapeutics Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 75. Neos Therapeutics Recent Development

Table 76. Mallinckrodt Company Details

Table 77. Mallinckrodt Business Overview

Table 78. Mallinckrodt Adult Attention Deficit and Hyperactivity Disorder Product

Table 79. Mallinckrodt Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 80. Mallinckrodt Recent Development

Table 81. Amneal Pharmaceuticals Company Details

Table 82. Amneal Pharmaceuticals Business Overview

Table 83. Amneal Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product

Table 84. Amneal Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 85. Amneal Pharmaceuticals Recent Development

Table 86. Noven Pharmaceuticals Company Details

Table 87. Noven Pharmaceuticals Business Overview

Table 88. Noven Pharmaceuticals Adult Attention Deficit and Hyperactivity Disorder Product

Table 89. Noven Pharmaceuticals Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 90. Noven Pharmaceuticals Recent Development

Table 91. Purdue Parma Company Details

Table 92. Purdue Parma Business Overview

Table 93. Purdue Parma Adult Attention Deficit and Hyperactivity Disorder Product

Table 94. Purdue Parma Revenue in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025) & (US$ Million)

Table 95. Purdue Parma Recent Development

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

Table 99. Authors List of This Report

List of Figures

Figure 1. Adult Attention Deficit and Hyperactivity Disorder Picture

Figure 2. Global Adult Attention Deficit and Hyperactivity Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Type: 2024 VS 2031

Figure 4. Stimulant Features

Figure 5. Non-stimulant Features

Figure 6. Global Adult Attention Deficit and Hyperactivity Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Others Case Studies

Figure 11. Adult Attention Deficit and Hyperactivity Disorder Report Years Considered

Figure 12. Global Adult Attention Deficit and Hyperactivity Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Adult Attention Deficit and Hyperactivity Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Region: 2024 VS 2031

Figure 15. Global Adult Attention Deficit and Hyperactivity Disorder Market Share by Players in 2024

Figure 16. Global Top Adult Attention Deficit and Hyperactivity Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adult Attention Deficit and Hyperactivity Disorder as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Adult Attention Deficit and Hyperactivity Disorder Revenue in 2024

Figure 18. North America Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 20. United States Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 24. Germany Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Adult Attention Deficit and Hyperactivity Disorder Market Share by Region (2020-2031)

Figure 32. China Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 40. Mexico Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Adult Attention Deficit and Hyperactivity Disorder Market Share by Country (2020-2031)

Figure 44. Turkey Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Adult Attention Deficit and Hyperactivity Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Takeda Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 48. Johnson & Johnson Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 49. Novartis Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 50. Eli Lilly Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 51. Tris Pharma Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 52. Neos Therapeutics Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 53. Mallinckrodt Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 54. Amneal Pharmaceuticals Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 55. Noven Pharmaceuticals Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 56. Purdue Parma Revenue Growth Rate in Adult Attention Deficit and Hyperactivity Disorder Business (2020-2025)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Neurology Equipment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32U11385

Wed Mar 05 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Adult Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32G9531

Fri Feb 28 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-25W5936

Fri Feb 28 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Children Attention Deficit and Hyperactivity Disorder Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13S9800

Fri Feb 28 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions